- Ticker
- ACON
- Price
- 0.70
- Stock movement down
- -0.04 (-5.43%)
- Company name
- Aclarion Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Health Information Services
- Markedsværdi
- 5.44M
- Ent værdi
- 3.95M
- Pris/omsætning
- 108.95
- Pris/bog
- 1.85
- Udbytte afkast
- -
- Udbyttevækst
- -
- Vekst år
- -
- FCF-udbetaling
- -8.41%
- Efterfølgende P/E
- -
- Fremtidig P/E
- -
- PEG
- -
- EPS-vekst
- -
- 1 års afkast
- -
- 3 års afkast
- -
- 5 års afkast
- -
- 10 års afkast
- -
Senest opdateret: 2023-01-27
UDBYTTE
ACON betaler ikke udbytte
VÆRDIANSÆTTELSE
Værdiansættelsesforhold
Loading...
Værdiansættelsesforhold-data
| Efterfølgende P/E | - |
| Pris til OCF | - |
| Pris til FCF | - |
| Pris til EBITDA | - |
| EV i forhold til EBITDA | - |
Værdiansættelse (salg/bogført værdi)
Loading...
Værdiansættelse (salg/bogført værdi)-data
| Pris til omsætning | 108.95 |
| Pris til egenkapital | 1.85 |
| EV i forhold til salg | 79.14 |
ØKONOMI
Pr. aktie
Loading...
Data pr. aktie
| Aktuelt antal aktier | 7.82M |
| EPS (TTM) | -1.20 |
| FCF pr. aktie (TTM) | -0.63 |
Resultatopgørelse
Loading...
Resultatopgørelse-data
| Omsætning (TTM) | 49.90K |
| Bruttofortjeneste (TTM) | -14.33K |
| Driftsindkomst (TTM) | -5.84M |
| Nettoindkomst (TTM) | -9.41M |
| EPS (TTM) | -1.20 |
| EPS (1 år frem) | -0.42 |
Marginer
Loading...
Marginer-data
| Bruttomargin (TTM) | -28.71% |
| Driftsmargin (TTM) | -11703.93% |
| Fortjenstmargin (TTM) | -18863.43% |
Balance
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
| Kontanter | 2.66M |
| Nettotilgodehavender | 25.50K |
| Omsætningsaktiver i alt | 2.88M |
| Goodwill | 0.00 |
| Immaterielle aktiver | 1.22M |
| Ejendomme, anlæg og udstyr | 0.00 |
| Sum aktiver | 4.10M |
| Kreditor | 718.28K |
| Kortfristet/nuværende langsigtet gæld | 0.00 |
| Summen af kortfristede forpligtelser | 1.17M |
| Sum gæld | 1.17M |
| Aktionærernes egenkapital | 2.93M |
| Materielle nettoaktiver | 1.72M |
Likviditet
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
| Likviditet fra driften (TTM) | -4.75M |
| Investeringsudgifter (TTM) | 188.34K |
| Fri pengestrøm (TTM) | -4.94M |
| Udbetalt udbytte (TTM) | 415.52K |
Finansiel indkomst
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
| Egenkapitalafkast | -320.96% |
| Afkast af aktiver | -229.52% |
| Afkast af investeret kapital | -320.96% |
| Kontant afkast af investeret kapital | -168.52% |
INFORMATION OM AKTIER
Aktiediagram
Loading...
Aktiekurs-data
| Åbning | 0.73 |
| Daglig høj | 0.74 |
| Daglig lav | 0.68 |
| Daglig volumen | 18K |
| Højeste gennem alle tider | 2.72 |
| 1 års analytiker estimat | 3.00 |
| Beta | - |
| EPS (TTM) | -1.20 |
| Udbytte pr. aktie | - |
| Ex-div dato | - |
| Næste dato for resultatpræsentation | 1 Mar 2023 |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| ACON | S&P500 | |
| Nuværende prisfald fra top notering | -74.44% | -15.08% |
| Højeste prisfald | -85.66% | -56.47% |
| Højeste efterår dato | 27 Dec 2022 | 9 Mar 2009 |
| Gennemsnitlig fald fra toppen | -62.90% | -11.49% |
| Gennemsnitlig tid til nyt højdepunkt | 194 days | 13 days |
| Maks. tid til nyt højdepunkt | 193 days | 1805 days |
OPLYSNINGER OM VIRKSOMHEDEN
Markedsværdi
5.44M
Markedsværdi kategori
Small-cap
Beskrivelse
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Personale
3
Hjemmeside
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
USA
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
Broomfield, CO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers ...
17. januar 2023
Broomfield, Colorado--(Newsfile Corp. - January 17, 2023) - Aclarion, Inc., (NASDAQ: ACON) (NASDAQ: ACONW) ("Aclarion" or the "Company"), a healthcare technology company that is leveraging biomarkers ...
17. januar 2023
Broomfield, CO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers...
22. december 2022
Development of this program supports Aclarion’s commitment to lead with strong clinical evidence and engage the payer community through key opinion leader advocacy. Broomfield, CO, Dec. 21, 2022 (GLOB...
21. december 2022
Dr. Uribe is the fourth national KOL to join the Aclarion team this year. Development of this program supports Aclarion’s commitment to lead with strong clinical evidence and engage the payer communit...
19. december 2022
Strengthens portfolio by addressing the anaerobic bacteria that can seed into the intervertebral disc, proliferate, and accelerate painful disc degeneration. Successful commercialization of IP holds t...
1. december 2022
Aclarion ( NASDAQ:ACON ) Third Quarter 2022 Results Key Financial Results Net loss: US$1.63m (loss widened by 90% from...
16. november 2022
/ Aclarion, Inc. (NASDAQ:ACON)(NASDAQ:ACONW) ("Aclarion" or the "Company"), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help phys...
25. oktober 2022
Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians ...
24. oktober 2022
Presentation on Tuesday, October 25th at 9:00 AM PT Broomfield, Colorado--(Newsfile Corp. - October 12, 2022) - Aclarion, Inc., (NASDAQ: ACON) (NASDAQ: ACONW) ("Aclarion" or the "Company"), a healthca...
12. oktober 2022
Næste side